semaglutide or tirzepatide. Tirzepatide vs Semaglutide vs Tirzepatide vs Liraglutide
Description
The science is moving fast, and we are only beginning to see what is possible. In 2025, a big focus in GLP-1 research has been expanding beyond single-pathway GLP-1 receptor agonists
Promotes healthy glucose metabolism and balance
Patients should not start, stop, or change these medicines based only on social media, ads, or another persons experience
Bottom line: Given the current lack of research, its typically best to play it safe and avoid taking semaglutide while breastfeeding
